Cardiac resynchronization in chronic heart failure.
By William T Abraham, W. Fisher, Andrew L. Smith, D. Delurgio, Angel R. Leon, Evan Loh, D. Kocovic, Milton Packer, A. Clavell, David L. Hayes and 7 more. New England Journal of Medicine, 2002
4,520 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/3b53332c38cf05279adb1765f95eb3bc765952e0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- T. Horwich
- Jeroen J. Bax
- J. Cleland
- Helmut Baumgartner
- Rick A. Nishimura
- J. Halperin
- Paulus Kirchhof
In Surgery
Citations in the corpus
- Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure (2003, background): “The rationales were that (1) prolonging LV filling time would improve LVEF; (2) that shortening IVMD would coordinate right ventricular and LV contraction, improve interventricular dyssynchrony, and optimize ventricular interaction; and (3) that shortening ICT would coordinate LV contraction and imp”
- Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. (2003, methodology): “Published randomized trials of cardiac resynchronization have been inconclusive in this regard.(17,31,36) To determine whether cardiac resynchronization decreases mortality from progressive heart failure, we conducted a meta-analysis.”
- Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) (2005, background): “Study enrollment criteria consisted of (1) chronic atrial fibrillation for >30 days; (2) requirement for AV node ablation and pacing therapy to manage medically refractory rapid ventricular rates; (3) symptoms limiting ambulation to <450 m with a 6-minute hallway walk test; and (4) stable medical th”
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Both for GDMT and other recommended drug treatment regimens, the reader is advised to confirm dosages with product insert material and to evaluate carefully for contraindications and drug-drug interactions.”